These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 25600647)

  • 1. β-arrestin-1 mediates nicotine-induced metastasis through E2F1 target genes that modulate epithelial-mesenchymal transition.
    Pillai S; Trevino J; Rawal B; Singh S; Kovacs M; Li X; Schell M; Haura E; Bepler G; Chellappan S
    Cancer Res; 2015 Mar; 75(6):1009-20. PubMed ID: 25600647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nicotine induces cell proliferation by beta-arrestin-mediated activation of Src and Rb-Raf-1 pathways.
    Dasgupta P; Rastogi S; Pillai S; Ordonez-Ercan D; Morris M; Haura E; Chellappan S
    J Clin Invest; 2006 Aug; 116(8):2208-2217. PubMed ID: 16862215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nicotinic acetylcholine receptors induce c-Kit ligand/Stem Cell Factor and promote stemness in an ARRB1/ β-arrestin-1 dependent manner in NSCLC.
    Perumal D; Pillai S; Nguyen J; Schaal C; Coppola D; Chellappan SP
    Oncotarget; 2014 Nov; 5(21):10486-502. PubMed ID: 25401222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nicotine-Mediated Regulation of Nicotinic Acetylcholine Receptors in Non-Small Cell Lung Adenocarcinoma by E2F1 and STAT1 Transcription Factors.
    Schaal C; Chellappan S
    PLoS One; 2016; 11(5):e0156451. PubMed ID: 27228072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of Sox2 and stemness by nicotine and electronic-cigarettes in non-small cell lung cancer.
    Schaal CM; Bora-Singhal N; Kumar DM; Chellappan SP
    Mol Cancer; 2018 Oct; 17(1):149. PubMed ID: 30322398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nicotine induces cell proliferation, invasion and epithelial-mesenchymal transition in a variety of human cancer cell lines.
    Dasgupta P; Rizwani W; Pillai S; Kinkade R; Kovacs M; Rastogi S; Banerjee S; Carless M; Kim E; Coppola D; Haura E; Chellappan S
    Int J Cancer; 2009 Jan; 124(1):36-45. PubMed ID: 18844224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epithelial-mesenchymal transition transcription factor ZEB1/ZEB2 co-expression predicts poor prognosis and maintains tumor-initiating properties in head and neck cancer.
    Chu PY; Hu FW; Yu CC; Tsai LL; Yu CH; Wu BC; Chen YW; Huang PI; Lo WL
    Oral Oncol; 2013 Jan; 49(1):34-41. PubMed ID: 22892238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nicotine upregulates FGFR3 and RB1 expression and promotes non-small cell lung cancer cell proliferation and epithelial-to-mesenchymal transition via downregulation of miR-99b and miR-192.
    Du X; Qi F; Lu S; Li Y; Han W
    Biomed Pharmacother; 2018 May; 101():656-662. PubMed ID: 29518612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of the polycomb protein Mel-18 enhances the epithelial-mesenchymal transition by ZEB1 and ZEB2 expression through the downregulation of miR-205 in breast cancer.
    Lee JY; Park MK; Park JH; Lee HJ; Shin DH; Kang Y; Lee CH; Kong G
    Oncogene; 2014 Mar; 33(10):1325-35. PubMed ID: 23474752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiR-338-3p inhibits epithelial-mesenchymal transition in gastric cancer cells by targeting ZEB2 and MACC1/Met/Akt signaling.
    Huang N; Wu Z; Lin L; Zhou M; Wang L; Ma H; Xia J; Bin J; Liao Y; Liao W
    Oncotarget; 2015 Jun; 6(17):15222-34. PubMed ID: 25945841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of ZNF746 suppresses invasion and epithelial to mesenchymal transition in H460 non-small cell lung cancer cells.
    Kim B; Sohn EJ; Jung JH; Shin EA; You OH; Im J; Kim SH
    Oncol Rep; 2014 Jan; 31(1):73-8. PubMed ID: 24145959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment with insulin-like growth factor 1 receptor inhibitor reverses hypoxia-induced epithelial-mesenchymal transition in non-small cell lung cancer.
    Nurwidya F; Takahashi F; Kobayashi I; Murakami A; Kato M; Minakata K; Nara T; Hashimoto M; Yagishita S; Baskoro H; Hidayat M; Shimada N; Takahashi K
    Biochem Biophys Res Commun; 2014 Dec; 455(3-4):332-8. PubMed ID: 25446090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ZEB1 drives epithelial-to-mesenchymal transition in lung cancer.
    Larsen JE; Nathan V; Osborne JK; Farrow RK; Deb D; Sullivan JP; Dospoy PD; Augustyn A; Hight SK; Sato M; Girard L; Behrens C; Wistuba II; Gazdar AF; Hayward NK; Minna JD
    J Clin Invest; 2016 Sep; 126(9):3219-35. PubMed ID: 27500490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ZEB1-responsive genes in non-small cell lung cancer.
    Gemmill RM; Roche J; Potiron VA; Nasarre P; Mitas M; Coldren CD; Helfrich BA; Garrett-Mayer E; Bunn PA; Drabkin HA
    Cancer Lett; 2011 Jan; 300(1):66-78. PubMed ID: 20980099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcription factor E2F1 promotes EMT by regulating ZEB2 in small cell lung cancer.
    Wang T; Chen X; Qiao W; Kong L; Sun D; Li Z
    BMC Cancer; 2017 Nov; 17(1):719. PubMed ID: 29115924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ID1 facilitates the growth and metastasis of non-small cell lung cancer in response to nicotinic acetylcholine receptor and epidermal growth factor receptor signaling.
    Pillai S; Rizwani W; Li X; Rawal B; Nair S; Schell MJ; Bepler G; Haura E; Coppola D; Chellappan S
    Mol Cell Biol; 2011 Jul; 31(14):3052-67. PubMed ID: 21606196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Silibinin inhibits β-catenin/ZEB1 signaling and suppresses bladder cancer metastasis via dual-blocking epithelial-mesenchymal transition and stemness.
    Wu K; Ning Z; Zeng J; Fan J; Zhou J; Zhang T; Zhang L; Chen Y; Gao Y; Wang B; Guo P; Li L; Wang X; He D
    Cell Signal; 2013 Dec; 25(12):2625-33. PubMed ID: 24012496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of LKB1 in epithelial-mesenchymal transition (EMT) of human lung cancer cells.
    Roy BC; Kohno T; Iwakawa R; Moriguchi T; Kiyono T; Morishita K; Sanchez-Cespedes M; Akiyama T; Yokota J
    Lung Cancer; 2010 Nov; 70(2):136-45. PubMed ID: 20207041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic and pharmacologic inhibition of mTORC1 promotes EMT by a TGF-β-independent mechanism.
    Mikaelian I; Malek M; Gadet R; Viallet J; Garcia A; Girard-Gagnepain A; Hesling C; Gillet G; Gonzalo P; Rimokh R; Billaud M
    Cancer Res; 2013 Nov; 73(22):6621-31. PubMed ID: 24078802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of a PEAK1/ZEB1 signaling axis during TGFβ/fibronectin-induced EMT in breast cancer.
    Agajanian M; Runa F; Kelber JA
    Biochem Biophys Res Commun; 2015 Sep; 465(3):606-12. PubMed ID: 26297948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.